Bioequivalence is a term in pharmacokinetics used to assess the expected in vivo biological equivalence of two proprietary preparations of a drug. Dissolution testing of immediate release solid oral dosage forms august 1997. In vitro dissolution and in silico modeling shortcuts in bioequivalence testing. The food and drug administration fda is announcing. Biorelevant dissolution test methods to asses bioequivalence of drug products dissertation zur erlangung des doktorgrades. Dissolution bioavailability bioequivalence download. It is a key analytical test used for detecting physical changes in an active pharmaceutical ingredient api and in the formulated product. Need for bioequivalence studies new product is intended to be a substitute for an approved medicinal product as a pharmaceutical equivalent or alternative to ensure clinical performance of such drug products bioequivalence studies are conducted if there is. Regulatory perspectives on strengthdependent dissolution. Fasting bioequivalence study parameter test reference ratio 90% c. Auc0t least squares geometric means, ratio of means, and 90% confidence intervals. This site is like a library, use search box in the widget to get ebook that you want.
Design of dissolution media for invitro bioequivalence. Please conduct comparative dissolution testing on 12 dosage units each of all strengths of the test and reference products. Prior to 2015, the us food and drug administration fda only considered biowaivers for class i drugs. Acceptance criteria for similarity and equivalence of dissolution profiles v. Division of bioequivalence i office of bioequivalence office of generic drugs, cder, fda dissolution similarity workshop university of maryland school of pharmacy, may 2122, 2019. Dissolution technologies february 2012 65 meeting report. Bioequivalence testing, using the dissolution profile.
In vivo bioequivalence, or simply bioequivalence, is commonly referred to as an evaluation study conducted to establish equality of mostly two oral products such as tablet or capsule. It may be used to waive in vivo bioequivalence be study. In vitro bioequivalence be pathways marilyn martinez, ph. Guideline for bioavailability and bioequivalence ich. The role of dissolution studies inscreening formulations and as a regulatory requirement. Agilent dissolution seminar series welcome agilent dissolution. When similarity testing is applied to support the approval of lower strengths of the same. In the next two sections, an overview regarding design and analysis of in vivo and in vitro bioequivalence testing for generic development are provided. Dissolution testing of immediate release solid oral dosage. The selection of the batch of comparator product used in a bioequivalence study should be based on assay content and dissolution data and is the responsibility of the applicant.
Dissolution testing is routinely used for stability and quality control purposes for both oral and nonoral dosage forms. Dissolution testing and similarity of dissolution profiles31 appendix ii. A decision regarding the acceptability of the waiver request will. Api, and dissolution characteristics of the drug product. Asean guideline for the conduct of bioequivalence studies.
Dissolution testing and acceptance criteria for immediaterelease. The emergence and dissolution of hierarchy pharmaceutical dissolution testing drugs and the pharmaceutical sciences. The guidance was originally published in november 1996. Federal register guidance for industry on clozapine. Guideline for bioequivalence studies of generic products index section 1. Assessment of bioequivalence 1 bioequivalence range, parameters, data transformation and statistical analysis 2 acceptance criteria iii.
In vitro dissolution testing for solid oral dosage forms. The statistical design needed to getregulatory approval. In a sciencebased approach, bcs allows waiver of in vivo bioavailability and bioequivalence testing for immediaterelease solid dosage forms for class i and iii compounds when they exhibit rapid or very. Dissolution profile similarity testing and any conclusions drawn from the results e. Moore jw, flanner hh 1996 proposed difference factor 1 and similarity factor 2 for the comparison of dissolution profiles. In vitro dissolution similarity as a surrogate for in vivo. Please note that a dissolution methods database is available to the public at the ogd website at.
A comparative study of the invitro dissolution profiles. Studies of dissolution profiles will be beneficial to learn the characteristics of a comparator or branded drug, to apply the learning to evaluating the quality of a generic meeting report. Establishing virtual bioequivalence and clinically. Bioequivalence testing is based on the comparative assessment of bioavailability of two or more formulae of the same active ingredient, administered in the same way yilmaz and elmas, 2010. Dissolution testing is a requirement for all solid oral dosage forms and is used in all phases of development for product release and stability testing 1. The objective of this article is to summarize how dissolution testing is used for the approval of safe and effective generic drug products in the united states us. For bioequivalence assessment of the seven in vitro tests, the fda classifies statistical methods as either the nonprofile analysis or the profile analysis. Testing, and in vivo bioequivalence documentation supacir. This bcs approach provides an opportunity to waive in vivo pharmacokinetic bioequivalence testing for certain categories of immediaterelease drug products. In bioequivalence studies, the plasma concentration time curve is generally used to assess the rate and extent of absorption. Unless otherwise justified, the assayed content of. Api characterisation, formulation evaluation, stability testing bioavailability bioequivalence in vitro in vivo relationships.
Dissolution testing is an in vitro technique of great importance in formulation and. Pharmaceutics free fulltext in vitro dissolution and. Selected pharmacokinetic parameters and preset acceptance limits allow the final decision on bioequivalence of the tested products. Waiver of in vivo bioavailability and bioequivalence for immediaterelease solid oral dosage forms based on the biopharmaceutics classification system is submitted in the application. The optimized media could be employed to study the dissolution profiles of 3tc in bioequivalence studies. Invitro dissolution testing indicated that the 3tc was stable and drug release is uniform from tablet dosage forms. Keywords bioequivalence, pharmacokinetics, biowaiver, in vitro dissolution, generics. Modified release solid oral dosage forms scaleup and postapproval changes. In vivo bioequivalence and in vitro dissolution testing. In vitro bioequivalence be pathways marilyn martinez.
Click download or read online button to get dissolution bioavailability bioequivalence book now. Invitro dissolution testing or drug release testing may be used for seeking waiver of required product to conduct invivo bioavailability or bioequivalence studies. Guideline for bioequivalence studies of generic products. Bioequivalence recommendation office of generic drugs keywords. Aapsnifdc joint workshop on dissolution testing, biowaiver, and bioequivalence. The purpose of this guidance document is to provide general recommendations for dissolution testing, approaches for setting dissolution specifications related to.
Pa ge 2 of 47 document control version date authors comments e 2. Thereby, by applying the most conservative guidelines for bioequivalence be testing, it. Case b or case c dissolution testing may also be required. Guideline for bioequivalence studies for formulation changes of oral solid dosage forms index. However, because of potentially significant adverse. Dissolution similarity testing for demonstration of. In vitro dissolution testing is an important tool used for development and approval of generic dosage forms. Dissolution testing, and in vivo bioequivalence documentation1995 fda guidances waiver of in vivo bioavailability andwaiver of in vivo bioavailability and bioequivalence studies for immediaterelease solid oral dosage forms based on biopharmaceutics classification system 2000. Dissolution similarity testing for demonstration of bioequivalence case studies zhen zhang, ph. Thereafter, the fda biowaiver to class iii drugs was a convergence with other health legislative authorities, including the european medicines agency ema and the world health organization who. Fda issued draft guidance on dissolution testing and specification criteria for immediaterelease solid oral dosage forms containing biopharmaceutics classification system class. Auc, the area under the concentration time curve, reflects the extent of exposure. Your pdf brochure was successfully sent to your email.
Reflection paper on the dissolution specification for. One of several applications of poppbpk modeling is in the emerging field of virtual bioequivalence vbe, where it can be. For a drug product that does not have a dissolution test method in the united states pharmacopeia usp, the fda dissolution methods database provides information on dissolution methods presently recommended by the division of bioequivalence, office of generic drugs. If two products are said to be bioequivalent it means that they would be expected to be, for all intents and purposes, the same. Physiologicallybased population pharmacokinetic modeling poppbpk coupled with in vitro biopharmaceutics tools such as biorelevant dissolution testing can serve as a powerful tool to establish virtual bioequivalence and set clinically relevant specifications. Type c in the case of changes that are likely to have a significant impact on formulation quality and performance, in vivo bioequivalence testing should be conducted unless otherwise justified. Introduction comparison of therapeutic performances of two medicinal products cantaining the same active substance is a critical means of assessing the. In 1996, shah, tsong and sathe formed a working group to develop and evaluate methods for the comparison of dissolution profiles.
Equivalence testing is the natural approach to many statistical problems. Quick view what is the difference between a divorce and a dissolution. Paracetamol is n4hydroxyphenyl acetamide, with empirical formula c 8 h 9 no 2. Guideline for bioequivalence studies for formulation. Bioequivalence who prequalification of medicines programme. Dissolution profile comparisons are used by the pharmaceutical industry to assess the similarity in the dissolution characteristics of two formulations to decide whether the implemented changes, usually minormoderate in nature, will have an impact on the in vitroin vivo performance of the drug product. In vitro dissolution testing and in vivo bioequivalence documentation.
1445 422 98 929 911 1041 197 108 658 367 458 1498 163 329 973 1282 1467 87 1287 734 979 950 1281 948 881 636 343 1418 907 1091 39 1148 1092 664 1285